These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 21257890)

  • 21. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
    Langer DL; van der Kwast TH; Evans AJ; Sun L; Yaffe MJ; Trachtenberg J; Haider MA
    Radiology; 2008 Dec; 249(3):900-8. PubMed ID: 19011187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
    Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
    Lim HK; Kim JK; Kim KA; Cho KS
    Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
    Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
    Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
    AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
    Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
    AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology.
    Yoshimitsu K; Kiyoshima K; Irie H; Tajima T; Asayama Y; Hirakawa M; Ishigami K; Naito S; Honda H
    J Magn Reson Imaging; 2008 Jan; 27(1):132-9. PubMed ID: 18050334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.
    Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L
    BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.
    Tamada T; Sone T; Jo Y; Toshimitsu S; Yamashita T; Yamamoto A; Tanimoto D; Ito K
    J Magn Reson Imaging; 2008 Sep; 28(3):720-6. PubMed ID: 18777532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy.
    Rosenkrantz AB; Prabhu V; Sigmund EE; Babb JS; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2013 Oct; 201(4):840-6. PubMed ID: 24059373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors.
    Sherwin JC; Mirmilstein G; Pedersen J; Lawrentschuk N; Bolton D; Mills J
    J Urol; 2010 May; 183(5):1808-14. PubMed ID: 20303103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
    Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
    AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.